glp-1 agonist dopamine GLP-1s Like Ozempic May Be a New Treatment for Addiction GLP-1 Agonists: Expanding Horizons in

A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice The study examines the effectiveness of novel peptides that are a combination of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon

Lancet 14:110 Son JW, Kim S (2020) Comprehensive review of current and upcoming anti-obesity drugs

It was decided that at the moment, the benefits demonstrated by Saxenda outweigh its risks

Key Takeaway between GIP & GLP-1 Mounjaro Dual-Hormone Injection: (GIP) Glucose-dependent insulinotropic polypeptide: GIP works alongside GLP-1 to support insulin response and metabolic function

Dual-acting oral GLP-1s are not yet available, but they are expected in the future